Design, Synthesis and Biological Evaluation of Novel Morpholinopyrimidine-5-carbonitrile Derivatives As Dual PI3K/mTOR Inhibitors

Overview

Journal RSC Med Chem

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2024 Feb 23

PMID 38389871

Authors

Ghada S Rady

Moshira A El Deeb

Marwa T M Sarg

Azza T Taher

Amira A Helwa

Affiliations

Soon will be listed here.

Abstract

In this study, novel morpholinopyrimidine-5-carbonitriles were designed and synthesized as dual PI3K/mTOR inhibitors and apoptosis inducers. The integration of a heterocycle at position 2, with or without spacers, of the new key intermediate 2-hydrazinyl-6-morpholinopyrimidine-5-carbonitrile (5) yielded compounds 6-10, 11a-c and 12a-h. The National Cancer Institute (USA) tested all compounds for antiproliferative activity. Schiff bases, 12a-h analogs, were the most active ones. The most promising compounds 12b and 12d exhibited excellent antitumor activity against the leukemia SR cell line, which is the most sensitive cell line, with IC 0.10 ± 0.01 and 0.09 ± 0.01 μM, respectively, along with significant effects on PI3Kα/PI3Kβ/PI3Kδ with IC values of 0.17 ± 0.01, 0.13 ± 0.01 and 0.76 ± 0.04 μM, respectively, for 12b and 1.27 ± 0.07, 3.20 ± 0.16 and 1.98 ± 0.11, respectively, for 12d compared to LY294002. Compared to Afinitor, these compounds inhibited mTOR with IC values of 0.83 ± 0.05 and 2.85 ± 0.17 μM, respectively. Annexin-V and propidium iodide (PI) double labeling showed that compounds 12b and 12d promote cytotoxic leukemia SR apoptosis. Compounds 12b and 12d also caused a G2/M cell cycle arrest in the leukaemia SR cell line. The findings of this study indicate that the highest effect was observed for 12b, which was supported by western blot and docking analysis.

References

Chaube U, Chhatbar D, Bhatt H . 3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer. Bioorg Med Chem Lett. 2016; 26(3):864-874. DOI: 10.1016/j.bmcl.2015.12.075. View

Zou Z, Tao T, Li H, Zhu X . mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci. 2020; 10:31. PMC: 7063815. DOI: 10.1186/s13578-020-00396-1. View

Helwa A, El-Dydamony N, A Radwan R, Abdelraouf S, Abdelnaby R . Novel antiproliferative agents bearing morpholinopyrimidine scaffold as PI3K inhibitors and apoptosis inducers; design, synthesis and molecular docking. Bioorg Chem. 2020; 102:104051. DOI: 10.1016/j.bioorg.2020.104051. View

Magaway C, Kim E, Jacinto E . Targeting mTOR and Metabolism in Cancer: Lessons and Innovations. Cells. 2019; 8(12). PMC: 6952948. DOI: 10.3390/cells8121584. View

Lei F, Sun C, Xu S, Wang Q, Ouyang Y, Chen C . Design, synthesis, biological evaluation and docking studies of novel 2-substituted-4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as dual PI3Kα/mTOR inhibitors. Eur J Med Chem. 2016; 116:27-35. DOI: 10.1016/j.ejmech.2016.03.033. View

Kaur R, Chaudhary S, Kumar K, Gupta M, Rawal R . Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review. Eur J Med Chem. 2017; 132:108-134. PMC: 7115489. DOI: 10.1016/j.ejmech.2017.03.025. View

Bae H, Lim W, Bazer F, Whang K, Song G . Mitigation of ER-stress and inflammation by chemokine (C-C motif) ligand 21 during early pregnancy. Dev Comp Immunol. 2019; 94:73-84. DOI: 10.1016/j.dci.2019.01.016. View

Abd El-Aleam R, George R, Lee K, Keeton A, Piazza G, Kamel A . Design and synthesis of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as PDE 4B inhibitors endowed with bronchodilator activity. Arch Pharm (Weinheim). 2019; 352(8):e1900002. DOI: 10.1002/ardp.201900002. View

Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C . A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995; 184(1):39-51. DOI: 10.1016/0022-1759(95)00072-i. View

10.

Ram V . Chemotherapeutic agents, XVIII: Synthesis of pi-deficient pyrimidines and fused pyrimidines as leishmanicidal agents. Arch Pharm (Weinheim). 1990; 323(11):895-9. DOI: 10.1002/ardp.19903231103. View

11.

Takeuchi H, Baba M, Shigeta S . An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds. J Virol Methods. 1991; 33(1-2):61-71. DOI: 10.1016/0166-0934(91)90008-n. View

12.

Cicenas J, Zalyte E, Bairoch A, Gaudet P . Kinases and Cancer. Cancers (Basel). 2018; 10(3). PMC: 5876638. DOI: 10.3390/cancers10030063. View

13.

Lakshmanan I, Batra S . Protocol for Apoptosis Assay by Flow Cytometry Using Annexin V Staining Method. Bio Protoc. 2016; 3(6). PMC: 4943750. DOI: 10.21769/bioprotoc.374. View

14.

Akinleye A, Avvaru P, Furqan M, Song Y, Liu D . Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics. J Hematol Oncol. 2013; 6(1):88. PMC: 3843585. DOI: 10.1186/1756-8722-6-88. View

15.

Gomez V, Galazi M, Weitsman G, Monypenny J, Al-Salemee F, Barber P . HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models. Mol Cancer Ther. 2022; 21(4):667-676. PMC: 7612588. DOI: 10.1158/1535-7163.MCT-21-0320. View

16.

Kashiyama T, Oda K, Ikeda Y, Shiose Y, Hirota Y, Inaba K . Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423. PLoS One. 2014; 9(2):e87220. PMC: 3913610. DOI: 10.1371/journal.pone.0087220. View

17.

Xia P, Xu X . PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. Am J Cancer Res. 2015; 5(5):1602-9. PMC: 4497429. View

18.

Abu-Zaied M, Hammad S, Halaweish F, Elgemeie G . Sofosbuvir Thio-analogues: Synthesis and Antiviral Evaluation of the First Novel Pyridine- and Pyrimidine-Based Thioglycoside Phosphoramidates. ACS Omega. 2020; 5(24):14645-14655. PMC: 7315579. DOI: 10.1021/acsomega.0c01364. View

19.

El-Masry R, Kadry H, Taher A, Abou-Seri S . Comparative Study of the Synthetic Approaches and Biological Activities of the Bioisosteres of 1,3,4-Oxadiazoles and 1,3,4-Thiadiazoles over the Past Decade. Molecules. 2022; 27(9). PMC: 9102899. DOI: 10.3390/molecules27092709. View

20.

Venkatesh T, Bodke Y, Joy M, Dhananjaya B, Venkataraman S . Synthesis of Some Benzofuran Derivatives Containing Pyrimidine Moiety as Potent Antimicrobial Agents. Iran J Pharm Res. 2018; 17(1):75-86. PMC: 5937079. View